Bioequivalence Study Between "Dong-A Atorvastatin Tab" and "Lipitor Tab"
Status:
Recruiting
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
An Open-Label, Randomized, 2-sequence, 4-period, Fasting Condition, Single-dose, Per Oral,
Cross-over Study to Evaluate the Bioequivalence between "Dong-A Atorvastatin 80mg Tab" and
"Lipitor 80mg Tab" in Healthy Volunteers